Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

25.85
Delayed Data
As of Dec 07
 -0.16 / -0.62%
Today’s Change
25.55
Today|||52-Week Range
35.04
-23.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues6.3B5.7B5.4B5.3B
 
 
 
 
 
Cost of Goods Sold512.1M400.3M436.2M212.0M
 
 
 
 
 
Depreciation And Amortization706.5M534.6M561.5M563.1M
 
 
 
 
 
 
Operating ExpensesGross Income5.1B4.8B4.4B4.5B
 
 
 
 
 
General Expenses4.1B3.7B4.1B3.4B
 
 
 
 
 
Research And Development1.6B1.4B1.3B1.3B
 
 
 
 
 
Total Operating Expenses5.3B4.7B5.1B4.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income975.8M1.1B230.5M1.1B
 
 
 
 
 
Extraordinary Credit--0.000.0022.1M
 
 
Extraordinary Charge-367.0M-290.3M-454.4M-407.3M
 
 
 
 
 
Interest Expense On Debt288.1M147.5M151.1M160.3M
 
 
 
 
 
Equity In Earnings-6.9M-3.8M-7.7M-9.2M
 
 
 
 
 
Other Expenses464.7M51.7M353.9M79.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income798.2M683.1M-21.0M632.2M
 
 
 
 
 
Income Taxes-5.9M-92.1M-956.6K-294.0M
 
 
 
 
 
Minority Interest0.00-19.7M-26.8M-17.5M
 
 
 
 
Net Income797.2M607.0M-2.9M934.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.31$0.24$0.00$0.37
 
 
 
 
EPS Diluted$0.32$0.24-$0.00$0.37